Dmk Pharmaceuticals Corp (DMK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 02/28
(Values in U.S. thousands)
| 02-1995 | 02-1994 | 02-1993 | 02-1992 | 02-1991 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 747 | 643 | 196 | 298 | 850 |
| TOTAL | $747 | $643 | $196 | $298 | $850 |
| Non-Current Assets | |||||
| PPE Net | 12,490 | 10,707 | 7,554 | 6,944 | 6,818 |
| Other Non-Current Assets | 9,258 | 8,495 | 10,157 | 3,498 | 2,486 |
| TOTAL | $21,748 | $19,201 | $17,711 | $10,441 | $9,303 |
| Total Assets | $22,495 | $19,844 | $17,908 | $10,740 | $10,153 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 528 | 598 | 1,448 | 819 | 769 |
| Accounts payable and accrued liabilities | 7,664 | 7,698 | 7,183 | 5,680 | 3,934 |
| Other current liabilities | 1,005 | 432 | 1,314 | 319 | 537 |
| TOTAL | $10,128 | $8,751 | $10,378 | $7,300 | $5,468 |
| Non-Current Liabilities | |||||
| TOTAL | $1,262 | $1,109 | $1,135 | $1,101 | $1,077 |
| Total Liabilities | $11,390 | $9,860 | $11,513 | $8,401 | $6,545 |
| Shareholders' Equity | |||||
| Common Shares | 2 | 1 | 0 | 0 | 0 |
| Other shareholders' equity | -307 | -715 | -520 | 0 | 0 |
| TOTAL | $22,030 | $21,050 | $16,470 | $9,437 | $6,828 |
| Total Liabilities And Equity | $33,420 | $30,909 | $27,982 | $17,838 | $13,373 |